Join our Newsletter — 33% off our NHI Course
Home Glossary Governance, Ownership & Risk S.A.F.E. Criteria
Governance, Ownership & Risk

S.A.F.E. Criteria

← Back to Glossary
By NHI Mgmt Group Updated September 23, 2026 Domain: Governance, Ownership & Risk

S.A.F.E. criteria are a model review framework that evaluates whether an AI use case is ready for deployment. The framework examines Safety and risk, Accuracy, Fairness and bias, and Evidence. It is designed to surface clinical harm, performance gaps, inequity, and weak substantiation before a model affects care.

What the S.A.F.E. criteria evaluate

S.A.F.E. criteria are a pre-deployment review lens for AI use cases, not a model score by itself. They ask whether the proposed use is safe enough to proceed by testing for foreseeable harm, measurable performance quality, bias, and the strength of the evidence behind the claim.

The practical value is that it forces a team to separate technical optimism from operational readiness. A model can look strong in development and still be unsuitable for care if its failure modes are clinically meaningful, its outputs are inconsistent, or the supporting validation is too thin to justify real-world use.

Safety, accuracy, fairness, and evidence as separate checks

Each element of S.A.F.E. answers a different question. Safety looks at whether the use case could create harm, accuracy asks whether the system behaves reliably for the intended task, fairness examines whether the model may work unevenly across groups, and evidence asks whether the claims are backed by credible validation rather than anecdote.

Keeping those checks distinct matters because a model can excel in one dimension and fail in another. For example, an AI tool may be accurate on average but still unsafe in edge cases, or it may be well-validated overall while producing biased results for a subgroup that is clinically important.

  • Safety is about adverse outcomes, not just technical errors.
  • Accuracy is about task performance in the intended setting, not benchmark performance alone.
  • Fairness is about unequal impact, not only statistical parity.
  • Evidence is about the quality and relevance of substantiation for deployment.

Why S.A.F.E. matters in clinical review

In healthcare settings, deployment decisions need more than model performance metrics. Review frameworks like S.A.F.E. help surface whether the use case could affect diagnosis, triage, documentation, or workflow in ways that create patient harm, reinforce inequity, or rely on claims that have not been adequately demonstrated.

That is why the framework is strongest when it is used before a model reaches production. It gives reviewers a structured way to challenge assumptions, identify where a use case depends on limited evidence, and avoid treating statistical performance as proof of clinical suitability.

For teams building governance around AI use, external assurance criteria such as SOC 2 Trust Services Criteria (AICPA) can complement S.A.F.E. when the deployment question includes trust, availability, and control discipline.

How reviewers should apply the framework

The most useful way to apply S.A.F.E. is as a pre-launch gate with explicit sign-off, not as a vague checklist. Reviewers should require each dimension to be answered with concrete evidence, then decide whether the use case is acceptable, needs mitigation, or should be blocked until the gaps are closed.

Common misunderstanding: S.A.F.E. does not mean the model is guaranteed to be safe, fair, or accurate in every context. It means the team has deliberately tested those questions and can justify deployment against the intended clinical use.

Practitioner takeaway: Treat S.A.F.E. as a governance control, not a marketing label, and require the evidence standard to match the real-world impact of the model.

Risk and Threat Considerations

AI review frameworks fail when they are used as a documentation exercise instead of a control. The main risk is false confidence, where a model passes a superficial review even though its errors, bias, or weak evidence could still drive harmful decisions once it is embedded in care.

Failure mechanism: If the review process does not force grounded evaluation of safety, accuracy, fairness, and evidence, deployment can proceed on incomplete validation, masking harmful failure modes until they affect patients or operations.

Impact: The result can be clinical harm, discriminatory outcomes, degraded trust, and avoidable rework when weaknesses appear only after the system is already influencing care.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST CSF 2.0 and NIST AI RMF set the technical controls, while ISO/IEC 42001:2023 define the regulatory obligations.

FrameworkControl / ReferenceRelevance
NIST CSF 2.0GV.RM — Risk Management StrategyS.A.F.E. is a deployment-governance review that manages AI use case risk before release.
Recommendation — Use governance review to decide whether the AI use case is acceptable to deploy.
NIST AI RMFGOVERN — GovernThe framework is about assessing trustworthiness and harm before deployment.
MEASURE — MeasureS.A.F.E. depends on testing model performance, bias, and evidence quality.
Recommendation — Establish accountable AI governance to evaluate safety, fairness, and evidence before launch. Measure model performance and bias with validation evidence tied to the intended clinical setting.
ISO/IEC 42001:2023A.5 — AI Policy and ObjectivesS.A.F.E. reflects policy-level criteria for approving AI use in an organisation.
Recommendation — Define approval criteria that require safety, accuracy, fairness, and evidence before deployment.

Practitioner Guidance

What to watch for: The framework is most useful when each criterion can be defended with specific evidence tied to the exact use case and population. If reviewers cannot explain why a model is safe, accurate, fair, and sufficiently evidenced for the intended setting, the deployment decision is not ready.

Governance implication: Assign clear ownership for each criterion so that safety, performance, bias review, and evidentiary review are not treated as interchangeable responsibilities. The framework works best when it produces a documented go, no-go, or revise decision.

Deepen Your Knowledge

Sign up to our weekly newsletter — get 33% off our NHI Foundation Level Course

    NHIMG Editorial Note
    Reviewed and updated by the NHIMG editorial team on September 23, 2026.
    NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org